分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Structural and Lipidomic Alterations of Striatal Myelin in 16p11.2 Deletion Mouse Model of Autism Spectrum Disorder

Ju Jun, Yang Xiuyan, Jiang Jian, Wang Dilong, Zhang Yumeng, Zhao Xiaofeng, Fang Xiaoyi, Liao Huanquan, Zheng Lei, Li Shupeng, Hou Sheng-Tao, Liang Liyang, Pan Yihang, Li Huiliang, Li Ningning

Journal:Frontiers in Cellular Neuroscience

IF:5.51

DOI:10.3389/fncel.2021.718720

PMID:34483844

Published:2021-08-12

research field:肿瘤学分子生物学药理学免疫学中医

Abstract

Myelin abnormalities have been observed in autism spectrum disorder (ASD). In this study, we seek to discover myelin-related changes in the striatum, a key brain region responsible for core ASD features, using the 16p11.2 deletion (16p11.2±) mouse model of ASD. We found downregulated expression of multiple myelin genes and decreased myelin thickness in the striatum of 16p11.2± mice versus wild type controls. Moreover, given that myelin is the main reservoir of brain lipids and that increasing evidence has linked dysregulation of lipid metabolism to ASD, we performed lipidomic analysis and discovered decreased levels of certain species of sphingomyelin, hexosyl ceramide and their common precursor, ceramide, in 16p11.2± striatum, all of which are major myelin components. We further identified lack of ceramide synthase 2 as the possible reason behind the decrease in these lipid species. Taken together, our data suggest a role for myelin and myelin lipids in ASD development.

本文使用的Yeasen产品

购物车
客服
转染试用